Supernus Pharmaceuticals (SUPN) Announces Release of Exciting New Clinical Data on Trokendi XR™
11/6/2013 9:43:26 AM
ROCKVILLE, Md., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq:SUPN), a specialty pharmaceutical company, today announced that new clinical data will be released at the American Epilepsy Society (AES) Meeting this coming December in Washington DC.
Help employers find you! Check out all the jobs and post your resume.